Long noncoding RNAs with peptide-encoding potential identified in esophageal squamous cell carcinoma:

Bo Zhou1, Yuyang Wu2, Pei Cheng3

  • 1Medical Research Center & Institute of Digestive Disease, The Second Affiliated Hospital of Zhengzhou University, China.

Molecular Oncology
|March 25, 2023
PubMed

Insights

Researchers identified novel peptide-coding long noncoding RNAs (lncRNAs) in esophageal squamous cell carcinoma (ESCC). The KDM4A-AS1 peptide reduced ESCC cell viability and migration by impacting fatty acid metabolism and redox processes.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • Knowledge regarding long noncoding RNA (lncRNA)-encoded peptides in esophageal squamous cell carcinoma (ESCC) is limited.
  • Identifying functional lncRNA-derived peptides is crucial for understanding cancer biology.

Purpose of the Study:

  • To identify novel peptide-coding long noncoding RNAs (lncRNAs) in esophageal squamous cell carcinoma (ESCC).
  • To investigate the functional role of the KDM4A-AS1 ORF-encoded peptide in ESCC progression.

Main Methods:

  • Weighted gene co-expression network analysis (WGCNA) of ESCC clinical samples.
  • Ribosome footprinting, open reading frame (ORF) prediction, mass spectrometry (MS), and western blotting.
  • Co-immunoprecipitation and cellular/molecular experiments to determine protein interactions and functional impact.

Main Results:

  • Six lncRNA ORFs with peptide-coding potential were identified, including KDM4A-AS1.
  • The KDM4A-AS1-encoded peptide significantly reduced ESCC cell viability and migration.
  • The peptide interacted with 103 proteins involved in fatty acid metabolism and redox processes, inhibiting key enzymes and altering cellular energetics.

Conclusions:

  • Multiple lncRNAs with translational potential were simultaneously identified in ESCC using a multi-omics approach.
  • The lncRNA KDM4A-AS1-encoded peptide acts as a tumor suppressor by modulating fatty acid metabolism and redox balance in ESCC.
  • This study provides novel strategies for identifying lncRNA-encoded peptides and highlights their potential as therapeutic targets.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K